ACTN2 mutations are associated with a range of cardiac phenotypes, including but not limited to dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) [35]. This evidence concerns the gene ACTN2 and hypertrophic cardiomyopathy.